Increasing the inflammatory competence of macrophages with IL-6 or with combination of IL-4 and LPS restrains the invasiveness of pancreatic cancer cells

Journal of Cancer

Volumn 7, Issue 1, 2016, Pages 42-49

  Salmiheimo, Aino N E ^a   Mustonen, Harri K ^a   Vainionpää, Sanna A A ^a   Shen, Zhanlong ^b   Kemppainen, Esko A J ^a   Seppänen, Hanna E ^a   Puolakkainen, Pauli A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Invasion; M1; M2; Macrophages; Pancreatic adenocarcinoma

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MATRIGEL;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PHENOTYPE; TUMOR INVASION;

EID: 84954471342     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.12923     Document Type: Article

References (31)

1. [Internet] National Cancer Institute, SEER Cancer Statistics Review, 1975-2012. http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=22&pageSEL=sect_22_table.08.html.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867.
3. Ekbom A, McLaughlin JK, Nyren O. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993; 329: 1502-1503.
4. Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014; 26: 192-197. doi: 10.1016/j.cellsig.2013.11.004.
5. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature Rev Immunol. 2008; 8: 958-969. doi: 10.1038/nri2448.
6. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008; 66: 1-9.
7. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A. 2004; 101: 4560-4565.
8. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011; 167: e211-9. doi: 10.1016/j.jss.2009.05.026.
9. Puolakkainen P, Koski A, Vainionpaa S, Shen Z, Repo H, Kemppainen E, et al. Anti-inflammatory macrophages activate invasion in pancreatic adenocarci noma by increasing the MMP9 and ADAM8 expression. Med Oncol. 2014; 31:884. doi: 10.1007/s12032-014-0884-9.
10. Menen RS, Hassanein MK, Momiyama M, Suetsugu A, Moossa AR, Hoffman RM, et al. Tumor-educated macrophages promote tumor growth and peritoneal metastasis in an orthotopic nude mouse model of human pancreatic cancer. In Vivo. 2012; 26: 565-569.
11. Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012; 181: 1895-1899. doi: 10.1016/j.ajpath.2012.08.044.
12. Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol. 2013; 281: 51-61. doi: 10.1016/j.cellimm.2013.01.010.
13. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nature Rev Immunol. 2008; 8: 533-544. doi: 10.1038/nri2356.
14. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol. 2007; 178: 5245-5252.
15. Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol. 2011; 2011: 565187. doi: 10.1155/2011/565187.
16. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009; 457: 200-204. doi: 10.1038/nature07475.
17. Bode JG, Ehlting C, Haussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal. 2012; 24: 1185-1194. doi: 10.1016/j.cellsig.2012.01.018.
18. Van Dyken SJ, Locksley RM. Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol. 2013; 31: 317-343. doi: 10.1146/annurev-immunol-032712-095906.
19. Shen Z, Kauttu T, Seppanen H, Vainionpaa S, Ye Y, Wang S, et al. Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro. Acta Oncol. 2013; 52: 852-860. doi: 10.3109/0284186X.2012.718444.
20. Rey-Giraud F, Hafner M, Ries CH. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS ONE. 2012; 7: e42656. doi: 10.1371/journal.pone.0042656.
21. Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren H, Vogel I, et al. Tumor-associated macrophages exhibit pro-and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer. 2014; 135: 843-861. doi: 10.1002/ijc.28736.
22. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006; 66: 605-612.
23. Dinarello CA. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 2010;29: 317-329. doi: 10.1007/s10555-010-9229-0.
24. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9: 361-371. doi: 10.1038/nrc2628.
25. Friess H, Guo XZ, Nan BC, Kleeff J, Buchler MW. Growth factors and cytokines in pancreatic carcinogenesis. Ann N Y Acad Sci. 1999; 880: 110-121.
26. Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013; 2013: 968549. doi: 10.1155/2013/968549.
27. Li J, Lau G, Chen L, Yuan YF, Huang J, Luk JM, et al. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS ONE. 2012; 7: e46264. doi: 10.1371/journal.pone.0046264.
28. Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014; 2014: 292376. doi: 10.1155/2014/292376.
29. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012; 21: 309-322. doi: 10.1016/j.ccr.2012.02.022.
30. Teng MW, Vesely MD, Duret H, McLaughlin N, Towne JE, Schreiber RD, et al. Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res. 2012; 72: 3987-3996. doi: 10.1158/0008-5472.CAN-12-1337.
31. Shen Z, Seppanen H, Kauttu T, Vainionpaa S, Ye Y, Wang S, et al. Vasohibin-1 expression is regulated by transforming growth factor-beta/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells. J Interferon Cytokine Res. 2013; 33: 428-433. doi: 10.1089/jir.2012.0046.